中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
6期
43-45
,共3页
帕瑞昔布钠%术后镇痛%效果%腔镜%甲状腺切除术
帕瑞昔佈鈉%術後鎮痛%效果%腔鏡%甲狀腺切除術
파서석포납%술후진통%효과%강경%갑상선절제술
Parecoxib sodium%Postoperative analgesia%Effect%Laparoscopic%Thyroidectomy
目的 观察帕瑞昔布钠联合静脉自控镇痛(PCA)在腔镜甲状腺术后的镇痛效果.方法 将在气管插管全身麻醉下接受腔镜甲状腺大部分切除术的48例患者随机分为两组:观察组26例患者术毕静脉注射帕瑞昔布钠40 mg后连接PCA泵,12h后追加帕瑞昔布钠40 mg,而对照组22例在术毕仅连接PCA泵.于术后4、8、12和24 h时点采用视觉模拟评分法(VAS)进行疼痛评分,同时观测PCA按压次数和用药总量.结果 观察组术后4、8、12和24 h时点VAS疼痛评分及PCA按压次数和用药总量均明显低于对照组,差异有统计学意义(P<0.05).结论 帕瑞昔布钠能明显增强腔镜甲状腺术后的镇痛效果,减少PCA的用药量.
目的 觀察帕瑞昔佈鈉聯閤靜脈自控鎮痛(PCA)在腔鏡甲狀腺術後的鎮痛效果.方法 將在氣管插管全身痳醉下接受腔鏡甲狀腺大部分切除術的48例患者隨機分為兩組:觀察組26例患者術畢靜脈註射帕瑞昔佈鈉40 mg後連接PCA泵,12h後追加帕瑞昔佈鈉40 mg,而對照組22例在術畢僅連接PCA泵.于術後4、8、12和24 h時點採用視覺模擬評分法(VAS)進行疼痛評分,同時觀測PCA按壓次數和用藥總量.結果 觀察組術後4、8、12和24 h時點VAS疼痛評分及PCA按壓次數和用藥總量均明顯低于對照組,差異有統計學意義(P<0.05).結論 帕瑞昔佈鈉能明顯增彊腔鏡甲狀腺術後的鎮痛效果,減少PCA的用藥量.
목적 관찰파서석포납연합정맥자공진통(PCA)재강경갑상선술후적진통효과.방법 장재기관삽관전신마취하접수강경갑상선대부분절제술적48례환자수궤분위량조:관찰조26례환자술필정맥주사파서석포납40 mg후련접PCA빙,12h후추가파서석포납40 mg,이대조조22례재술필부련접PCA빙.우술후4、8、12화24 h시점채용시각모의평분법(VAS)진행동통평분,동시관측PCA안압차수화용약총량.결과 관찰조술후4、8、12화24 h시점VAS동통평분급PCA안압차수화용약총량균명현저우대조조,차이유통계학의의(P<0.05).결론 파서석포납능명현증강강경갑상선술후적진통효과,감소PCA적용약량.
Objective To observe the effect of parecoxib sodium combined intravenous patient-controlled analgesia(PCA) in the postoperative analgesia for laparoscopic thyroidectomy.Methods Fortyeight patients who underwent laparoscopic thyroidectomy under tracheal intubation general anesthesia randomly divided into two groups,For the observation group 26 patients injected parecoxib sodium 40 mg then connected with PCA pumps after operations,12 hours after chasing parecoxib sodium 40 mg,while the control group 22 patients just connected with PCA pumps after operations.After 4,8,12 and 24 hour time points using VAS pain scores,while observing the PCA pressing times and medication total.Results Observation group after 4,8,12 and 24 hour time point VAS pain scores and PCA pressing times and medication total were significantly lower than that of control group,the difference was statistically significant (P < 0.05).Conclusions Parecoxib sodium can significantly enhance the analgesic effect of endoscopic thyroid surgery,and reduce the dosage of the PCA.